Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT03065400Phase 2Completed
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Chronic Phase MyelofibrosisPolycythemia VeraPost-essential Thrombocythemia Myelofibrosis+1 more
StudychairStart date: 2017-06-14

Research Network

Collaboration Network

21 collaborators·20 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Harvard Medical School Massachussets General Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John Mascarenhas, MD

Icahn School of Medicine at Mount Sinai

Moderately Similar
16 trials

Shared therapeutic areas:

Primary MyelofibrosisPost-Essential Thrombocythemia MyelofibrosisPolycythemia Vera+1 more

Worked with same sponsors:

John MascarenhasMassachusetts General Hospital+1 more
Collaborated on 1 trial
Similarity Score44%

Will Savage, MD PhD

Disc Medicine

Related
6 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraPost-Essential Thrombocythemia Myelofibrosis
Similarity Score23%

Ronald Hoffman, MD

Icahn School of Medicine at Mount Sinai

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia VeraPost-Essential Thrombocythemia Myelofibrosis

Worked with same sponsors:

John Mascarenhas
Similarity Score23%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera
Similarity Score15%

Rami Komrokji, MD

H. Lee Moffitt Cancer Center and Research Institute

Related
5 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera
Similarity Score15%

Srdan Verstovsek, MD

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera
Similarity Score15%

Mark Jones, MD

Incyte Corporation

Related
8 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera
Similarity Score15%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Polycythemia VeraPrimary Myelofibrosis
Similarity Score15%

Brenda Sandmaier

Fred Hutch/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Polycythemia VeraPrimary Myelofibrosis
Similarity Score15%

Neal Flomenberg, MD

Thomas Jefferson University

Related
7 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03065400Phase 2StudyChair

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Chronic Phase MyelofibrosisPolycythemia VeraPost-essential Thrombocythemia Myelofibrosis+1 more
Completed

All 1 trials loaded